ALK-IN-29 (compound 4c) exhibits notable inhibitory activity against tyrosine kinases such as ALK, CDK2/CyclinE1, and FAK, with the strongest inhibition observed against ALK kinase, showing a 40.63% inhibition rate at a concentration of 10 µM. ALK-IN-29 is useful for cancer research.
Molekulargewicht:
504.42
CAS Nummer:
[2244986-40-9]
Formel:
C26H26BrN5O
Target-Kategorie:
CDK
T201159
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten